IMPLANTABLE OPTICAL GLUCOSE SENSING

• US 20130006069A1
• Filed: 06/30/2011
• Published: 01/03/2013
• Est. Priority Date: 06/30/2011
• Status: Active Grant

• Current Assignee: GluSense Ltd.
• Original Assignee: GluSense Ltd.
• Inventors: GIL, Tamir, GROSS, Yossi, GRINBERG, Orly, WEISMAN, Itamar, HYMAN, Tehila, HYMAN, Boaz
• Granted Patent: US 9,037,205 B2
• Time in Patent Office: Days
• US Class Current: 600/316
• CPC Class Codes: A61B 5/0071 by measuring fluorescence emission
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/1459 invasive, e.g. introduced into the body by a catheter A61B5/1464 takes precedence

Abstract

Apparatus is provided for detecting an analyte, configured to be implanted in a body of a subject. The apparatus includes an optical fiber having a distal portion and also a membrane permeable to the analyte. The membrane is coupled to the distal portion of the fiber and surrounding a sampling region at least in part, by being fitted over the distal portion of the fiber. Other embodiments are also described.

Claims

1. Apparatus for detecting an analyte, configured to be implanted in a body of a subject, the apparatus comprising:

an optical fiber having a distal portion; and

a membrane permeable to the analyte, the membrane coupled to the distal portion of the fiber and surrounding a sampling region at least in part, by being fitted over the distal portion of the fiber.

2. The apparatus according to claim 1, wherein the optical fiber comprises exactly one optical fiber.

3. The apparatus according to claim 1, wherein the membrane is attached to the distal portion of the fiber within 5 mm of a distal tip of the fiber.

4. The apparatus according to claim 1, wherein the membrane is attached to the distal portion of the optical fiber by glue.

5. The apparatus according to claim 1, further comprising a perforated tube surrounding the sampling region.

6. The apparatus according to claim 5, wherein the membrane surrounds the perforated tube.

7. The apparatus according to claim 5, wherein the perforated tube surrounds the membrane.

8. The apparatus according to claim 5, wherein the distal portion of the optical fiber is disposed within the perforated tube.

9. The apparatus according to claim 5, wherein the perforated tube comprises a material selected from the group consisting of:

metal and plastic.

10. The apparatus according to claim 1, wherein the sampling region has a shape selected from the group consisting of cylindrical and hemispherical.

11. The apparatus according to claim 1, wherein the membrane is shaped to define a hole therein that is sealed, the sealed hole located at a distal end of the sampling region relative to the optical fiber.

12. The apparatus according to claim 1, further comprising a stopper inserted into a distal end of the perforated tube relative to the optical fiber.

13. The apparatus according to claim 1, further comprising:

a light source configured to pass light through the optical fiber toward the sampling region; and

a detection system, configured to receive fluorescent light, through the optical fiber, from the sampling region, and to analyze the fluorescent light in order to determine an indication of a level of the analyte in the body of the subject.

14. The apparatus according to claim 13, wherein the detection system is configured to facilitate administration of a substance to the subject, in response to the determined indication of the level of the analyte.

15. The apparatus according to claim 13, wherein the detection system is configured to determine the indication of the level of the analyte, while outside of the body of the subject.

16. The apparatus according to claim 13, wherein the detection system is configured to be implanted in the body of the subject, and to determine the indication of the level of the analyte, while inside the body of the subject.

17. The apparatus according to claim 1, wherein the sampling region comprises biological matter, which changes a state thereof in response to a concentration of the analyte in the subject.

18. The apparatus according to claim 17, wherein:

the biological matter comprises a plurality of fluorescent proteins including a genetically-modified glucose receptor protein, and a cyan fluorescent protein (CFP) and a yellow fluorescent protein (YFP) coupled to the glucose receptor protein, and is configured such that;

when a glucose molecule from the subject interacts with the genetically-modified glucose receptor protein, the glucose receptor protein changes conformation as a result, and the two fluorescent proteins are in close enough proximity to each other so that the CFP acts as an energy donor and the YFP acts as an energy acceptor in a Fluorescence Resonance Energy Transfer (FRET) signaling system that indicates a concentration of glucose through the emission of electromagnetic radiation.

19. The apparatus according to claim 18, wherein the biological matter comprises a plurality of cells, which produce the genetically-modified glucose receptor proteins.

20. The apparatus according to claim 17, further comprising one or more alginate beads encasing the biological matter.

21. The apparatus according to claim 20, wherein each bead has a diameter of 40 um to 150 um.

22. The apparatus according to claim 20, wherein each bead has a diameter of 150 um to 600 um.

23. The apparatus according to claim 20, further comprising a perforated tube surrounding the sampling region, wherein each bead has a diameter equal to 60% to 80% of the internal diameter of the perforated tube.

24. The apparatus according to claim 20, wherein each bead has a diameter equal to 80% to 120% of a diameter of the optical fiber.

25. The apparatus according to claim 20, wherein the one or more alginate beads comprise exactly two alginate beads.

26. The apparatus according to claim 20, wherein the one or more alginate beads comprise exactly three alginate beads.

27-68. -68. (canceled)